TIBRENGA Trademark

Trademark Overview


On Friday, March 21, 2014, a trademark application was filed for TIBRENGA with the United States Patent and Trademark Office. The USPTO has given the TIBRENGA trademark a serial number of 79145817. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, March 21, 2024. This trademark is owned by NOVARTIS AG. The TIBRENGA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and for gastroenterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products
tibrenga

General Information


Serial Number79145817
Word MarkTIBRENGA
Filing DateFriday, March 21, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, March 21, 2024
Registration Number4590934
Registration DateTuesday, August 26, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 10, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and for gastroenterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products
Translation of Words in MarkThe wording "TIBRENGA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, July 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, April 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 24, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 25, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 1, 2014ASSIGNED TO EXAMINER
Saturday, May 3, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, May 21, 2014NOTICE OF PUBLICATION
Tuesday, June 10, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 26, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, September 25, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, July 24, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, October 24, 2020NOTIFICATION PROCESSED BY IB
Sunday, February 28, 2021NOTIFICATION PROCESSED BY IB
Thursday, May 1, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 25, 2014FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, July 24, 2020DEATH OF INTERNATIONAL REGISTRATION
Wednesday, October 16, 2024DEATH OF INTERNATIONAL REGISTRATION